UK to widen vaccine offer to help control monkeypox spread
People at great risk of monkeypox exposure will be offered Bavarian Nordic’s vaccine, Imvanex, under a new strategy to curb the UK outbreak.
By Jinshan Hong, bloomberg
The UK plans to increase the provision of vaccines to high-risk populations in an effort to contain the spread of monkeypox.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Bavarian Nordic CFO: More monkeypox orders may follow
For subscribers
